GLP-1 coverage in employer plans could double in 2024Findings from a recent employer survey on sentiment and adoption of GLP-1 medications by Accolade and Savanta on sentiment and adoption...
European Medicines Agency to discuss anaesthesia risk for weight-loss drugsThe European Medicines Agency (EMA) will assess the risk that patients on weight loss drugs such as semaglutide and tirzepatide may...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatment4 days ago